(Q22305875)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1449257

Passive immunization against poliomyelitis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1449257

Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 5. Reanalysis of results based on laboratory-confirmed cases

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1449257

Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1449257

Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1449257

Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. IV. Final report of results based on clinical diagnoses

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1449257

Antibodies for the prevention and treatment of viral diseases

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1449257

Poliovirus neurovirulence

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1449257

The role of antibody in experimental poliomyelitis; production of intracerebral immunity in monkeys by vaccination.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1449257

Poliomyelitis virus in human blood during the minor illness and the asymptomatic infection.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1449257

Use of immune serum globulin (human) as prophylaxis against poliomyelitis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1449257

Neutralization of three immunological types of poliomyelitis virus by human gamma globulin

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1449257

Experimental studies on passive immunization against poliomyelitis. II. The prophylactic effect of human gamma globulin on paralytic poliomyelitis in cynomolgus monkeys after virus feeding.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1449257

Poliomyelitis virus in blood of orally infected monkeys and chimpanzees

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1449257

Experimental studies on passive immunization against poliomyelitis. I. Protection with human gamma globulin against intramuscular inoculation, and combined passive and active immunization.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1449257

Experimental studies on passive immunization against poliomyelitis. III. Passive-active immunization and pathogenesis after virus feeding in chimpanzees

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1449257

A history of immune globulin therapy, from the Harvard crash program to monoclonal antibodies

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1449257

Differentiation of types of poliomyelitis viruses; the grouping of 14 strains into three basic immunological types

29 November 2018

1 reference

12 December 2020

Patenting the Sun. Polio and the Salk Vaccine. Jane S. Smith. Morrow, New York, 1990. 413 pp. + plates. $22.95

1 reference

12 December 2020

The association of parenteral injections with poliomyelitis

1 reference

12 December 2020

Vaccination Against Acute Anterior Poliomyelitis

1 reference

12 December 2020

Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 3. Preliminary report of results based on clinical diagnosis

1 reference

12 December 2020

The powerful placebo: from ancient priest to modern physician

1 reference

12 December 2020

Active Immunization Against Poliomyelitis

1 reference

12 December 2020

EVALUATION of gamma globulin in prophylaxis of paralytic poliomyelitis in 1953: summary of the report of the National Advisory Committee for evaluation of gamma globulin

1 reference

12 December 2020

GAMMA globulin as a prophylactic in poliomyelitis

1 reference

12 December 2020

Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Limitations in the use of gamma globulin in poliomyelitis

1 reference

12 December 2020

Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. I. Plan of controlled field tests and results of 1951 pilot study in Utah

1 reference

12 December 2020

GAMMA-GLOBULIN in the prevention and attenuation of measles

1 reference

12 December 2020

PREVENTION of whooping-cough by vaccination; a Medical Research Council investigation

1 reference

12 December 2020

Possibilities of specific prevention and treatment of poliomyelitis

1 reference

12 December 2020

Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 2. Conduct and early follow-up of 1952 Texas and Iowa-Nebraska studies

1 reference

12 December 2020

Studies in human subjects on active immunization against poliomyelitis. I. A preliminary report of experiments in progress

1 reference

12 December 2020

Immunization of monkeys with formalin-inactivated poliomyelitis viruses

1 reference

12 December 2020

RESEARCH on a vaccine for the prevention of poliomyelitis

1 reference

12 December 2020

Oral poliovirus vaccine. History of its development and prospects for eradication of poliomyelitis

1 reference

12 December 2020